Risk of gestational hypertension in women treated with serotonin and norepinephrine reuptake inhibitors: A comparative study in the EFEMERIS database

被引：0
|
作者：
Lacroix, Isabelle [1 ]
Araujo, Melanie [2 ]
Waser, Julie [3 ]
Hurault Delarue, Caroline [2 ]
Damase Michel, Christine [4 ]
机构：
[1] Univ Toulouse, CHU Toulouse, INSERM 1027, Toulouse, France
[2] Ctr Hosp Univ Toulouse, Reseau Regards Pharmacol Med & Clin, Inserm Umr 1295 Cerpop Equipe Sphere, Toulouse, France
[3] Ctr Hosp Univ Toulouse, Pharmacol Med & Clin, Inserm Umr 1295 Cerpop Equipe Sphere, Toulouse, France
[4] Univ Toulouse III, Fac Med, Pharmacol Med, Inserm CERPOP,CHU, Toulouse, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
535
引用
收藏
页码：239 / 240
页数：2
相关论文
共 50 条
  • [1] Risk of gestational hypertension in women treated with serotonin and norepinephrine reuptake inhibitors: A comparative study in the EFEMERIS database
    Araujo, M.
    Waser, J.
    Hurault-Delarue, C.
    Lacroix, I.
    Damase-Michel, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 67 - 68
  • [2] Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database
    Benevent, Justine
    Araujo, Melanie
    Karki, Sudip
    Delarue-Hurault, Caroline
    Waser, Julie
    Lacroix, Isabelle
    Tebeka, Sarah
    Damase-Michel, Christine
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (04)
  • [3] RISK OF PSYCHOSEXUAL DYSFUNCTION BETWEEN USERS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND SEROTONIN NOREPINEPHRINE REUPTAKE INHIBITORS
    Shewale, A. R.
    Shah, A.
    Painter, J.
    VALUE IN HEALTH, 2014, 17 (03) : A210 - A210
  • [4] Serotonin Reuptake Inhibitor and Pregnancy: Risk of Gestational Hypertension?
    Damase-Michel, Christine
    Duhalde, Veronique
    Hurault, Caroline
    Bourrel, Robert
    Montastruc, Jean Louis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S13 - S13
  • [5] Serotonin reuptake inhibitor and pregnancy: Risk of gestational hypertension?
    Damase-Michel, C.
    Duhalde, V.
    Delarue, C.
    Lacroix, I.
    Bourrel, R.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 51 - 51
  • [6] Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension
    Toh, Sengwee
    Mitchell, Allen A.
    Louik, Carol
    Werler, Martha M.
    Chambers, Christina D.
    Hernandez-Diaz, Sonia
    AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (03): : 320 - 328
  • [7] Selective serotonin reuptake inhibitor use and risk of gestational hypertension
    Toh, Sengwee
    Mitchell, Allen A.
    Chambers, Christina D.
    Louik, Carol
    Werler, Martha M.
    Hemandez-Diaz, Sonia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S15 - S15
  • [8] Risk of domperidone in pregnant women: A study in the EFEMERIS database
    Araujo, Melanie
    Vabre, Clementine
    Benevent, Justine
    Sommet, Agnes
    Damase-Michel, Christine
    Hurault-Delarue, Caroline
    Lacroix, Isabelle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 327 - 327
  • [9] Safety of Neuraminidase Inhibitors During Pregnancy: A Comparative Study in the EFEMERIS Database
    Beau, A.
    Hurault-Delarue, C.
    Montastruc, J.
    Damase-Michel, C.
    Lacroix, I.
    DRUG SAFETY, 2013, 36 (09) : 888 - 889
  • [10] Persistence with selective serotonin (norepinephrine) reuptake inhibitors in Germany-A retrospective database analysis
    Kap, Elisabeth
    Konrad, Marcel
    Kostev, Karel
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 247 : 156 - 160
12345